Chronic pancreatitis is the progressive disorder associated with the destruction of the pancreas. The most common symptoms are upper abdominal pain and diarrhea. As the disease becomes more chronic, patients can develop malnutrition and weight loss.

Prevalence estimates for CP are limited to only a few populations. The overall prevalence of CP shows high variability. In recent studies the prevalence ranges around 40-50 per 100,000 population.

Non-alcoholic etiologies are identified more frequently among women, and can account for up to 70% of cases.

Hospitalization in patients with CP could be due to AP flares, pain, maldigestion, and local complications. More than 90% of patients are hospitalized on at least one occasion in their lifetime for pain related to CP.

Chronic Pancreatitis is found to be more common in men than women.

Key Pharma Companies in the Chronic Pancreatitis market includes:
Kangen Pharmaceuticals
AzurRxBioPharma
Theraly Fibrosis
Aptalis Pharma
EURAND Pharmaceuticals
And many others

For more detailed information on Chronic Pancreatitis Market, visit: https://www.delveinsight.com/report-store/chronic-pancreatitis-market